Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human models for cancer active immunotherapy.

G Mathé

    Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]
    |February 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    This editorial reviews human models for cancer immunotherapy research. It differentiates trial types and discusses methodological and ethical considerations for active immunotherapy clinical trials.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Phase I trial of Perrimustine, a new cysteamine (2-chloroethyl) nitrosourea: an intrapatient escalation scheme.

    Anti-cancer drugs·1992
    Same author

    Radical tumor excision and cosmetic balance in the surgical treatment of breast carcinoma: biquadrantectomy.

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·1992
    Same author

    Is the "war against cancer" lost?

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·1992
    Same author

    Is the AIDS virus responsible for the disease?

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·1992
    Same author

    Retrospective study correlating clinical infectious history and peripheral blood T-cell subpopulations in cancer, GvH and HIV+ patients.

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·1992
    Same author

    Transplantation, immunity, tolerance and grafts. Dempster, Hasek "et les autres".

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·1992
    Same journal

    Characterization of a major natural killer activity in rat lungs.

    Biomedicine / [publiee pour l'A.A.I.C.I.G.]·1981
    Same journal

    Decreased phagocytosis and antibody-dependent cellular cytotoxicity (ADCC) in type-1 diabetes.

    Biomedicine / [publiee pour l'A.A.I.C.I.G.]·1981
    Same journal

    [Alveolar macrophages in asthmatic patients: study of their phagocytic function].

    Biomedicine / [publiee pour l'A.A.I.C.I.G.]·1981
    Same journal

    Effect of salbutamol, a putative cerebral beta agonist on sleep stages and interictal epileptic discharges.

    Biomedicine / [publiee pour l'A.A.I.C.I.G.]·1981
    Same journal

    Ganglioside content and pattern in tumor tissue of human neuroblastomas.

    Biomedicine / [publiee pour l'A.A.I.C.I.G.]·1981
    Same journal

    Protective effect of levamisole on carbon tetrachloride-induced lipid peroxidation and hepatotoxicity.

    Biomedicine / [publiee pour l'A.A.I.C.I.G.]·1981
    See all related articles

    Area of Science:

    • Oncology
    • Immunology
    • Clinical Research

    Background:

    • Cancer immunotherapy represents a significant advancement in oncology treatment.
    • Evaluating the efficacy of novel cancer therapies requires robust research models.
    • Understanding the nuances of clinical trial design is crucial for advancing immunotherapy.

    Purpose of the Study:

    • To analyze human models used in cancer immunotherapy research.
    • To differentiate between direct and indirect evidence of immunotherapy efficacy in clinical trials.
    • To discuss the methodological and ethical aspects of active immunotherapy trials.

    Main Methods:

    • Review of existing literature and clinical trial methodologies.
    • Categorization of immunotherapy trials based on comparison groups (therapeutic abstention, chemotherapy).

    Related Experiment Videos

  • Analysis of comparative trial designs (immunotherapy vs. chemotherapy, combination vs. chemotherapy alone).

    • Main Results:

    • Direct evidence of immunotherapy action is demonstrated by comparing it to therapeutic abstention.
    • Indirect evidence is shown by comparing immunotherapy to known chemotherapy effects or combination therapy to chemotherapy alone.
    • The editorial highlights the importance of carefully designed trials for assessing immunotherapy.

    Conclusions:

    • Methodological rigor is essential for validating immunotherapy efficacy.
    • Ethical considerations are paramount in the design and execution of cancer immunotherapy clinical trials.
    • Further refinement of human models and trial designs will accelerate progress in cancer immunotherapy.